GOLKYPA
Live / Applied — First extension granted (statement of use) (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 26 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98716504
- Mark type
- Stylized text
- Filed
- 26 Aug 2024
- Published for opposition
- 15 Jul 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biological preparations for human use in the fields of hematology, oncology and cell therapy for the treatment of cancer and blood disorders.
Owner
- Celgene Corporation, Princeton, NJ, US
- Celgene Corporation, Princeton, NJ, US
Prosecution history
- 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 1 GRANTED
- 12 Feb 2026 — SOU EXTENSION 1 FILED
- 12 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION
- 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Jun 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 04 Jun 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 04 Jun 2025 — FINAL REFUSAL E-MAILED
- 04 Jun 2025 — FINAL REFUSAL WRITTEN